Literature DB >> 17059791

Hypertension in black Americans as a special population: why so special?

David Stewart1, Wallace Johnson, Elijah Saunders.   

Abstract

Studies have shown that appropriate treatment of hypertension will reduce cardiovascular, renal, and cerebrovascular morbidity and mortality for all patients. Because hypertension has a multifaceted nature the disorder presents with unique features in prevalence, morbidity, and mortality among ethnic groups. Blacks, Hispanics, and Native Americans have been identified as special populations at risk for unique experiences with hypertension. Among these special populations, black Americans present unique issues in etiology, pathophysiology, severity, and response to treatment. This article reviews the varied aspects of hypertension detection, treatment, and control as they relate to the special population of black Americans.

Entities:  

Mesh:

Year:  2006        PMID: 17059791     DOI: 10.1007/s11886-006-0097-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  15 in total

1.  Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.

Authors:  Janice G Douglas; George L Bakris; Murray Epstein; Keith C Ferdinand; Carlos Ferrario; John M Flack; Kenneth A Jamerson; Wendell E Jones; Julian Haywood; Randall Maxey; Elizabeth O Ofili; Elijah Saunders; Ernesto L Schiffrin; Domenic A Sica; James R Sowers; Donald G Vidt
Journal:  Arch Intern Med       Date:  2003-03-10

2.  JNC 7--it's more than high blood pressure.

Authors:  Thomas E Kottke; Robert J Stroebel; Rebecca S Hoffman
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

3.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

4.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

5.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

Authors:  F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

6.  Hypertension in African-Americans.

Authors:  E Saunders
Journal:  Circulation       Date:  1991-04       Impact factor: 29.690

7.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

8.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Authors:  L Y Agodoa; L Appel; G L Bakris; G Beck; J Bourgoignie; J P Briggs; J Charleston; D Cheek; W Cleveland; J G Douglas; M Douglas; D Dowie; M Faulkner; A Gabriel; J Gassman; T Greene; Y Hall; L Hebert; L Hiremath; K Jamerson; C J Johnson; J Kopple; J Kusek; J Lash; J Lea; J B Lewis; M Lipkowitz; S Massry; J Middleton; E R Miller; K Norris; D O'Connor; A Ojo; R A Phillips; V Pogue; M Rahman; O S Randall; S Rostand; G Schulman; W Smith; D Thornley-Brown; C C Tisher; R D Toto; J T Wright; S Xu
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

9.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

10.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

View more
  5 in total

Review 1.  Racial disparities in outcomes after cardiac surgery: the role of hospital quality.

Authors:  Rohan Khera; Mary Vaughan-Sarrazin; Gary E Rosenthal; Saket Girotra
Journal:  Curr Cardiol Rep       Date:  2015-05       Impact factor: 2.931

2.  Gingival Fluid Inflammatory Biomarkers and Hypertension in African Americans.

Authors:  A Khocht; T Rogers; M N Janal; M Brown
Journal:  JDR Clin Trans Res       Date:  2017-02-01

3.  Intergenerational transmission of chronic illness self-care: results from the caring for hypertension in African American families study.

Authors:  Jan Warren-Findlow; Rachel B Seymour; Dena Shenk
Journal:  Gerontologist       Date:  2010-09-23

4.  Positive affect is associated with cardiovascular reactivity, norepinephrine level, and morning rise in salivary cortisol.

Authors:  B H Brummett; S H Boyle; C M Kuhn; I C Siegler; R B Williams
Journal:  Psychophysiology       Date:  2009-05-12       Impact factor: 4.016

5.  Predicting medication use in an elderly hypertensive sample: revisiting the Established Populations for Epidemiologic Studies of the Elderly Study.

Authors:  Mimi M Kim; Daniel L Howard; Jay S Kaufman; DaJuanicia Holmes
Journal:  J Natl Med Assoc       Date:  2008-12       Impact factor: 1.798

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.